FDA Warning Wire: Drug Ratings Nixed By Suspect Tests

The U.S. Food and Drug Administration this week escalated its long-running crusade against data manipulation in the Indian pharmaceutical industry, firing off missives to three companies and stripping generic drugs of...

Already a subscriber? Click here to view full article